ICD-10

ICD-10 code D61.82

You are here: Home > ICD-10-CM > D50-D89 > D60-D64 > D61 > D61.8

- ICD-10-CM
TABULAR LIST of DISEASES and INJURIES
- D50-D89
Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
- D60-D64
Aplastic and other anemias and other bone marrow failure syndromes
- D61
Other aplastic anemias and other bone marrow failure syndromes
- D61.8
Other specified aplastic anemias and other bone marrow failure syndromes

D61.82

Myelophthisis

ICD-10 code D61.82 for Myelophthisis

Leukoerythroblastic anemia
Myelophthisic anemia
Panmyelophthisis
Code also the underlying disorder, such as:
malignant neoplasm of breast (C50.-)
tuberculosis (A15.-)
Excludes1: idiopathic myelofibrosis (D47.1)
myelofibrosis NOS (D75.81)
myelofibrosis with myeloid metaplasia (D47.4)
primary myelofibrosis (D47.1)
secondary myelofibrosis (D75.81)
ICD-10
ATC
ICD-10 International Statistical Classification of Diseases and Related Health Problems 10th Revision
ICD-10

ICD-10 is the 10th revision of the International Statistical Classification of Diseases and Related Health Problems (ICD), a medical classification list by the World Health Organization (WHO).

It contains codes for diseases, signs and symptoms, abnormal findings, complaints, social circumstances, and external causes of injury or diseases.

ATC

The Anatomical Therapeutic Chemical (ATC) Classification System is used for the classification of active ingredients of drugs according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties.

It is controlled by the World Health Organization Collaborating Centre for Drug Statistics Methodology (WHOCC).

DDD

The defined daily dose (DDD) is a statistical measure of drug consumption, defined by the World Health Organization (WHO).

It is used to standardize the comparison of drug usage between different drugs or between different health care environments.

Home Contact Us